Raplon Side Effects
Generic name: rapacuronium
Note: This document provides detailed information about Raplon.
Applies to rapacuronium: intravenous powder for injection Side Effects associated with rapacuronium. Some dosage forms listed on this page may not apply specifically to the brand name Raplon.
Applies to rapacuronium: intravenous powder for injection.
Cardiovascular
Cardiovascular effects including hypotension (5.2%), tachycardia (3.2%), and bradycardia (1.5%) have been reported.[Ref]
Respiratory
Respiratory effect including bronchospasm (3.2%) have been reported.[Ref]
References
1. (2001) "Product Information. Raplon (rapacuronium)." Organon
2. Goudsouzian NG (2001) "Rapacuronium and bronchospasm." Anesthesiology, 94, p. 727-8
3. Kron SS (2001) "Severe bronchospasm and desaturation in a child associated with rapacuronium." Anesthesiology, 94, p. 923-4
4. Naguib M (2001) "How serious is the bronchospasm induced by rapacuronium?." Anesthesiology, 94, p. 924-5
5. Meakin GH, Pronske EH, Lerman J, Orr R, Joffe D, Savaree AM, Lynn AM (2001) "Bronchospasm after rapacuronium in infants and children." Anesthesiology, 94, p. 926-7
More about Raplon (rapacuronium)
Further information
Raplon side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.